Health Condition 1: E784- Other hyperlipidemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Serum Cholesterol (201 mg/dl or more) Serum TGLs (161 mg/dl or more) Serum HDL (below 40 mlg/dl) Serum LDL (131 mg/dl or more) Serum VLDL (41 mg/dl or more) will be included in the study.
Exclusion criteria
Exclusion criteria: Systemic Disorders Like Cardiac Disease,Renal Disease, And Neurological Diseases And Who Are Not Fit For Basti Karma Will Be Excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of Triphala kwatha administered in the schedule of Kala Basti rectal administration and oral administration of Triphala kwatha with Madhu in the management of Medoroga w.r.s to dyslipidemia. Timepoint: 3 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall improvement in Quality of life in Dyslipidemia. Reduction in sign and symptoms of Medoroga w.s.r. to Dyslipidemia Timepoint: 90 days | — |
Countries
India
Contacts
All India Institute Of Ayurveda